Clinical Trials Directory

Trials / Sponsors / AIM Vaccine Co., Ltd.

AIM Vaccine Co., Ltd.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA
SARS-CoV-2
Phase 22023-10-09
UnknownA Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA
SARS-CoV-2
Phase 12023-08-10
UnknownA Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chi
SARS-CoV-2
N/A2023-04-01
UnknownClinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad
SARS-CoV-2
Phase 32023-04-01
UnknownClinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
SARS-CoV-2
Phase 32023-03-25
UnknownClinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants
SARS-CoV-2
Phase 12023-02-01
UnknownA Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
SARS-CoV-2
Phase 32023-01-30
UnknownClinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Year
SARS-CoV-2
N/A2023-01-04
UnknownA Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China
SARS-CoV-2
N/A2022-09-26
UnknownA Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged
SARS-CoV-2
N/A2022-09-16
UnknownA Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Ov
SARS-CoV-2
N/A2022-09-13
CompletedClinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People
SARS-CoV-2
Phase 22022-03-16
UnknownClinical Trial of SARS-CoV-2 mRNA Vaccine in China
COVID-19
Phase 12021-07-31